Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost-effective strategy in spondyloarthritis
Sayam Dubash, Domini Bryer, John Fitton, Andrew Barr, Claire Vandevelde, Helena Marzo-Ortega and Jane Freeston
DOI: https://doi.org/10.7861/clinmedicine.19-2-s106
Clin Med March 2019 Sayam Dubash
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Rheumatology, Leeds Teaching Hospitals, Leeds, UK
Domini Bryer
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Rheumatology, Leeds Teaching Hospitals, Leeds, UK
John Fitton
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Rheumatology, Leeds Teaching Hospitals, Leeds, UK
Andrew Barr
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Rheumatology, Leeds Teaching Hospitals, Leeds, UK
Claire Vandevelde
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Rheumatology, Leeds Teaching Hospitals, Leeds, UK
Helena Marzo-Ortega
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Rheumatology, Leeds Teaching Hospitals, Leeds, UK
Jane Freeston
ALeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
BNIHR Biomedical Research Centre, Rheumatology, Leeds Teaching Hospitals, Leeds, UK
Article Tools
Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost-effective strategy in spondyloarthritis
Sayam Dubash, Domini Bryer, John Fitton, Andrew Barr, Claire Vandevelde, Helena Marzo-Ortega, Jane Freeston
Clinical Medicine Mar 2019, 19 (Suppl 2) 106-107; DOI: 10.7861/clinmedicine.19-2-s106
Citation Manager Formats
Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost-effective strategy in spondyloarthritis
Sayam Dubash, Domini Bryer, John Fitton, Andrew Barr, Claire Vandevelde, Helena Marzo-Ortega, Jane Freeston
Clinical Medicine Mar 2019, 19 (Suppl 2) 106-107; DOI: 10.7861/clinmedicine.19-2-s106
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.